Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) Sloan Ratio %: 25.41% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:ORZAX Orzaks Ilac Ve Kimya Sanayi Ticaret AS IST:ORZAX
18 GF Score
Price ₺87.50
! 3 Warning Signs
View Full Analysis

What is Orzaks Ilac Ve Kimyanayi Ticaret AS Sloan Ratio %?

Orzaks Ilac Ve Kimyanayi Ticaret AS IST:ORZAX -1.41% 18 Sloan Ratio % is 25.41% as of Dec. 2025. GuruFocus rates IST:ORZAX with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio for the quarter that ended in Dec. 2025 was 25.41%.

Warning Sign:

When sloan ratio (25.41)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Dec. 2025, Orzaks Ilac Ve Kimyanayi Ticaret AS has a Sloan Ratio of 25.41%, indicating earnings are more likely to be made up of accruals.


Orzaks Ilac Ve Kimyanayi Ticaret AS  (IST:ORZAX) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2025, Orzaks Ilac Ve Kimyanayi Ticaret AS has a Sloan Ratio of 25.41%, indicating earnings are more likely to be made up of accruals.


Orzaks Ilac Ve Kimyanayi Ticaret AS Sloan Ratio % Related Terms


Orzaks Ilac Ve Kimyanayi Ticaret AS Sloan Ratio % Historical Data

* Premium members only.

The historical data trend for Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orzaks Ilac Ve Kimyanayi Ticaret AS Sloan Ratio % Chart

Orzaks Ilac Ve Kimyanayi Ticaret AS Annual Data
Trend Dec23 Dec24 Dec25
Sloan Ratio %
-7.36 4.31 25.41

Orzaks Ilac Ve Kimyanayi Ticaret AS Semi-Annual Data
Dec23 Dec24 Dec25
Sloan Ratio % 0.00 4.31 25.41

IST:ORZAX vs KHC, GIS: Sloan Ratio % Comparison

For the Packaged Foods subindustry, Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orzaks Ilac Ve Kimyanayi Ticaret AS Sloan Ratio % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio % falls into.


IST:ORZAX
18GF Score
Orzaks Ilac Ve Kimya Sanayi Ticaret AS IST:ORZAX
Sloan Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orzaks Ilac Ve Kimyanayi Ticaret AS Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2025 )-Cash Flow from Operations (A: Dec. 2025 )
-Cash Flow from Investing (A: Dec. 2025 ))/Total Assets (A: Dec. 2025 )
=(1052.801--703.159
--484.907)/8819.958
=25.41%

Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio for the quarter that ended in Dec. 2025 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2025 )
=(-
-)/
=%

Orzaks Ilac Ve Kimyanayi Ticaret AS does not have enough years/quarters to calculate the Net Income, Cash Flow from Investing, and Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2025.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Sloan Ratio % →
What does a Sloan Ratio % of 25.41% mean?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a Sloan Ratio % of 25.41% as of Dec. 2025. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio % too high?
Orzaks Ilac Ve Kimyanayi Ticaret AS's current Sloan Ratio % is 25.41%. Overall, Orzaks Ilac Ve Kimyanayi Ticaret AS has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio % compare to KHC and GIS?
Orzaks Ilac Ve Kimyanayi Ticaret AS's Sloan Ratio % of 25.41% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Consumer Packaged Goods company?
A good Sloan Ratio % depends on the Consumer Packaged Goods industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors. Orzaks Ilac Ve Kimyanayi Ticaret AS's current Sloan Ratio % is 25.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS stock overvalued right now?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a current Sloan Ratio % of 25.41%. The current Sloan Ratio % is 25.41%. Orzaks Ilac Ve Kimyanayi Ticaret AS's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX), the current Sloan Ratio % is 25.41% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Orzaks Ilac Ve Kimyanayi Ticaret AS Business Description

Address Esentepe Mah, Buyukdere Cad, No:171, Metrocity Is Merkezi A Blok Kat:1, Sisli, Istanbul, TUR
Orzaks Ilac Ve Kimya Sanayi Ticaret AS operates as a sports nutrition brand. Its products are Vitamin Series, Vitamin D Series, Mineral Series, Magnesium Series, Omega 3 Series, Plant Extracts, Immune Series, Probiotic Series, Bone And Joint Series, and Others. The group offers its products under various brands such as Ocean, Day2Day, Imunol, Cosakondrin, Efervit, Bigflor, and Strains.
18GF Score

Get the complete analysis for IST:ORZAX

Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺87.50
Price